Phase II clinical trial of intratumoral application of TG1042 (adenovirus-interferon-gamma) in patients with advanced cutaneous T-cell lymphomas and multilesional cutaneous B-cell lymphomas.
Dummer R, Eichmüller S, Gellrich S, Assaf C, Dreno B, Schiller M, Dereure O, Baudard M, Bagot M, Khammari A, Bleuzen P, Bataille V, Derbij A, Wiedemann N, Waterboer T, Lusky M, Acres B, Urosevic-Maiwald M.
Dummer R, et al. Among authors: schiller m.
Mol Ther. 2010 Jun;18(6):1244-7. doi: 10.1038/mt.2010.52. Epub 2010 Apr 6.
Mol Ther. 2010.
PMID: 20372104
Free PMC article.
Clinical Trial.